Study in Patients With Asthma

Dey32 enrolled

Overview

The purpose of this study is to determine which dose of the investigational drug is safest and most effective compared to the control drug.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Asthma

Interventions

Formoterol FumarateDRUG

Eligibility

Sex: ALLMin age: 12 YearsMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: -Require regular use of an inhaled Beta-2-selective adrenergic agent Exclusion Criteria: * Active acute or chronic disorders of the respiratory system within one month prior to screening * Smoking history within the past 12 months or greater than a lifetime 10 pack-year smoking history * Recent surgical interventions such as lung lobectomy or resection (\< one year), or cardiothoracic interventions * Life-threatening systemic and debilitating diseases.

Locations (2)

Research Site

Denver, Colorado, United States

Research Site

Medford, Oregon, United States

Outcomes

Primary Outcomes

Measure of lung function.

Secondary Outcomes

Change in lung function, vital signs, physical examinations, clinical laboratory assessments, and adverse event reporting.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.